• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

23Andme Holding Co. (NQ: ME )

4.650 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 174,113
Open 4.700
Bid (Size) 4.650 (4)
Ask (Size) 4.710 (4)
Prev. Close 4.650
Today's Range 4.650 - 4.755
52wk Range 4.600 - 20.40
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
23andMe Regains Compliance With Nasdaq Listing Requirements
October 30, 2024
From 23andMe, Inc.
Via GlobeNewswire
23andMe Appoints Three New Independent Directors to Board
October 29, 2024
From 23andMe, Inc.
Via GlobeNewswire

Performance

YTD
-74.41%
-74.41%
1 Month
-36.99%
-36.99%
3 Month
-39.30%
-39.30%
6 Month
-53.92%
-53.92%
1 Year
-71.65%
-71.65%

More News

Read More
ASML's Latest Chapter in the Semiconductor Story
October 22, 2024
Via The Motley Fool
23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South
October 17, 2024
From 23andMe, Inc.
Via GlobeNewswire
Author Alok Sama on OpenAI, Bubbles, and When to Sell
October 16, 2024
Via The Motley Fool
23andMe Announces Completion of 1-for-20 Reverse Stock Split
October 16, 2024
From 23andMe, Inc.
Via GlobeNewswire
23andMe Announces 1-for-20 Reverse Stock Split
October 11, 2024
From 23andMe, Inc.
Via GlobeNewswire
23andMe Announces Mathew Knowles as New Brand Ambassador
October 08, 2024
From 23andMe, Inc.
Via GlobeNewswire
Legal Battle Brews Over 23andMe's Customer Data Breach Settlement And Arbitration Claimants
October 02, 2024
Via Benzinga
Topics Data Breach
Exposures Information Security
12 Health Care Stocks Moving In Friday's After-Market Session
September 27, 2024
Via Benzinga
23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating
September 25, 2024
From 23andMe, Inc.
Via GlobeNewswire
Independent Board Members Of Penny Stock 23andMe Resign, Call Out CEO Anne Wojcicki For Not 'Actionable Proposal' Despite Ample Time
September 18, 2024
Via Benzinga
General Mills, Steelcase And 3 Stocks To Watch Heading Into Wednesday
September 18, 2024
Via Benzinga
Independent Directors of 23andMe Resign from Board
September 17, 2024
From 23andMe, Inc.
Via GlobeNewswire
23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 Trial
September 15, 2024
From 23andMe, Inc.
Via GlobeNewswire
23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study
September 15, 2024
From 23andMe, Inc.
Via GlobeNewswire
One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All Populations
September 12, 2024
From 23andMe, Inc.
Via GlobeNewswire
23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024
September 03, 2024
From 23andMe, Inc.
Via GlobeNewswire
Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
August 29, 2024
Via Benzinga
Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program
August 28, 2024
From 23andMe, Inc.
Via GlobeNewswire
ME Stock Earnings: 23andMe Holding Beats EPS, Misses Revenue for Q1 2025
August 08, 2024
Via InvestorPlace
23andMe Reports First Quarter Fiscal 2025 Financial Results
August 08, 2024
From 23andMe, Inc.
Via GlobeNewswire
ME Stock Alert: CEO Anne Wojcicki Enters $200 Million Buyout Offer for 23andMe
August 02, 2024
Via InvestorPlace
23andMe Special Committee responds to CEO’s take-private proposal
August 02, 2024
From 23andMe, Inc.
Via GlobeNewswire
23andMe Announces CEO’s Take-Private Proposal
August 01, 2024
From 23andMe, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap